Biochemistry (Moscow)

, Volume 81, Issue 10, pp 1163–1172 | Cite as

New fluorescent macrolide derivatives for studying interactions of antibiotics and their analogs with the ribosomal exit tunnel

  • A. G. Tereshchenkov
  • A. V. Shishkina
  • V. V. Karpenko
  • V. A. Chertkov
  • A. L. Konevega
  • P. S. Kasatsky
  • A. A. Bogdanov
  • N. V. SumbatyanEmail author


Novel fluorescent derivatives of macrolide antibiotics related to tylosin bearing rhodamine, fluorescein, Alexa Fluor 488, BODIPY FL, and nitrobenzoxadiazole (NBD) residues were synthesized. The formation of complexes of these compounds with 70S E. coli ribosomes was studied by measuring the fluorescence polarization depending on the ribosome amount at constant concentration of the fluorescent substance. With the synthesized fluorescent tylosin derivatives, the dissociation constants for ribosome complexes with several known antibiotics and macrolide analogs previously obtained were determined. It was found that the fluorescent tylosin derivatives containing BODIPY FL and NBD groups could be used to screen the binding of novel antibiotics to bacterial ribosomes in the macrolide-binding site.

Key words

macrolides tylosin fluorescent derivatives nascent peptide exit tunnel fluorescent polarization 



(aminooxy)acetic acid




4,4-difluoro-5,7-dimethyl-4-bora-3a,4adiaza-s-indacene-3-pentanoic acid (BODIPY FL C5)
















ribosomal tunnel


trifluoroacetic acid




Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Supplementary material

10541_2016_323_MOESM1_ESM.pdf (371 kb)
New Fluorescent Macrolide Derivatives for Studying Interactions of Antibiotics and Their Analogs with the Ribosomal Exit Tunnel


  1. 1.
    Kannan, K., and Mankin, A. S. (2011) Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action, Ann. N. Y. Acad. Sci., 1241, 33–47.CrossRefPubMedGoogle Scholar
  2. 2.
    Wilson, D. N. (2014) Ribosome-targeting antibiotics and mechanisms of bacterial resistance, Nat. Rev. Microbiol., 12, 35–48.CrossRefPubMedGoogle Scholar
  3. 3.
    Bogdanov, A. A., Sumbatyan, N. V., Shishkina, A. V., Karpenko, V. V., and Korshunova, G. A. (2010) Ribosomal tunnel and translation regulation, Biochemistry (Moscow), 75, 1501–1516.CrossRefGoogle Scholar
  4. 4.
    Pestka, S. (1974) Binding of [14C]erythromycin to Escherichia coli ribosomes, Antimicrob. Agents Chemother., 6, 474–478.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Teraoka, H., and Nierhaus, K. H. (1979) Measurement of the binding of antibiotics to ribosomal particles by means of equilibrium dialysis, Methods Enzymol., 59, 862–866.CrossRefPubMedGoogle Scholar
  6. 6.
    Abelian, A., Walsh, A. P., Lentzen, G., Aboul-Ela, F., and Gait, M. J. (2004) Targeting the A site RNA of the Escherichia coli ribosomal 30S subunit by 2'-O-methyl oligoribonucleotides: a quantitative equilibrium dialysis binding assay and differential effects of aminoglycoside antibiotics, Biochem. J., 383, 201–208.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Fernandez-Munoz, R., Monro, R. E., Torres-Pinedo, R., and Vazquez, D. (1971) Substrateand antibiotic-binding sites at the peptidyl-transferase center of Escherichia coli ribosomes. Studies on the chloramphenicol, lincomycin and erythromycin sites, Eur. J. Biochem., 23, 185–193.CrossRefPubMedGoogle Scholar
  8. 8.
    Siegrist, S., Lagouardat, J., Moreau, N., and LeGoffic, F. (1981) Mechanism of action of a 16-membered macrolide. Binding of rosaramicin to the Escherichia coli ribosome and its subunits, Eur. J. Biochem., 115, 323–327.CrossRefPubMedGoogle Scholar
  9. 9.
    Llano-Sotelo, B., Dunkle, J., Klepacki, D., Zhang, W., Fernandes, P., Cate, J. H., and Mankin, A. S. (2010) Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis, Antimicrob. Agents Chemother., 54, 4961–4970.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Starosta, A. L., Karpenko, V. V., Shishkina, A. V., Mikolajka, A., Sumbatyan, N. V., Schluenzen, F., Korshunova, G. A., Bogdanov, A. A., and Wilson, D. N. (2010) Interplay between the ribosomal tunnel, nascent chain, and macrolides influences drug inhibition, Chem. Biol., 17, 504–514.CrossRefPubMedGoogle Scholar
  11. 11.
    Moazed, D., and Noller, H. F. (1987) Chloramphenicol, erythromycin, carbomycin and vernamycin B protect overlapping sites in the peptidyl transferase region of 23S ribosomal RNA, Biochimie, 69, 879–884.CrossRefPubMedGoogle Scholar
  12. 12.
    Xiong, L., Korkhin, Y., and Mankin, A. S. (2005) Binding site of the bridged macrolides in the Escherichia coli ribosome, Antimicrob. Agents Chemother., 49, 281–288.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Petropoulos, A. D., Kouvela, E. C., Dinos, G. P., and Kalpaxis, D. L. (2008) Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis, J. Biol. Chem., 283, 4756–4765.CrossRefPubMedGoogle Scholar
  14. 14.
    Tejedor, F., and Ballesta, J. P. (1985) Ribosome structure: binding site of macrolides studied by photoaffinity labeling, Biochemistry, 24, 467–472.CrossRefPubMedGoogle Scholar
  15. 15.
    Melançon, P., and Brakier-Gingras, L. (1985) Cross-linking of streptomycin to the 50S subunit of Escherichia coli with phenyldiglyoxal, Biochemistry, 24, 6089–6095.CrossRefPubMedGoogle Scholar
  16. 16.
    Oehler, R., Polacek, N., Steiner, G., and Barta, A. (1997) Interaction of tetracycline with RNA: photoincorporation into ribosomal RNA of Escherichia coli, Nucleic Acids Res., 25, 1219–1224.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Leach, K. L., Swaney, S. M., Colca, J. R., McDonald, W. G., Blinn, J. R., Thomasco, L. M., Gadwood, R. C., Shinabarger, D., Xiong, L., and Mankin, A. S. (2007) The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria, Mol. Cell., 26, 393–402.CrossRefPubMedGoogle Scholar
  18. 18.
    McFarlan, S. C., and Vince, R. (1984) Inhibition of peptidyltransferase and possible mode of action of a dipeptidyl chloramphenicol analog, Biochem. Biophys. Res. Commun., 122, 748–754.CrossRefPubMedGoogle Scholar
  19. 19.
    Xaplanteri, M. A., Andreou, A., Dinos, G. P., and Kalpaxis, D. L. (2003) Effect of polyamines on the inhibition of peptidyltransferase by antibiotics: revisiting the mechanism of chloramphenicol action, Nucleic Acids Res., 31, 5074–5083.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Dinos, G. P., Connell, S. R., Nierhaus, K. H., and Kalpaxis, D. L. (2003) Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation, Mol. Pharmacol., 63, 617–623.CrossRefPubMedGoogle Scholar
  21. 21.
    Vince, R., Weiss, D., and Pestka, S. (1976) Binding of Nsubstituted erythromycylamines to ribosomes, Antimicrob. Agents Chemother., 9, 131–136.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Langlois, R., Cantor, C. R., Vince, R., and Pestka, S. (1977) Interaction between the erythromycin and chloramphenicol binding sites on the Escherichia coli ribosome, Biochemistry, 16, 2349–2356.CrossRefPubMedGoogle Scholar
  23. 23.
    Brandt-Rauf, P., Vince, R., LeMahieu, R., and Pestka, S. (1978) Fluorescent assay for estimating the binding of erythromycin derivatives to ribosomes, Antimicrob. Agents Chemother., 14, 88–94.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Watkins, D., Norris, F. A., Kumar, S., and Arya, D. P. (2013) A fluorescence-based screen for ribosome binding antibiotics, Anal. Biochem., 434, 300–307.CrossRefPubMedGoogle Scholar
  25. 25.
    Llano-Sotelo, B., Hickerson, R. P., Lancaster, L., Noller, H. F., and Mankin, A. S. (2009) Fluorescently labeled ribosomes as a tool for analyzing antibiotic binding, RNA, 15, 1597–1604.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Jameson, D. M., and Ross, J. A. (2010) Fluorescence polarization/anisotropy in diagnostics and imaging, Chem. Rev., 110, 2685–2708.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Turconi, S., Shea, K., Ashman, S., Fantom, K., Earnshaw, D. L., Bingham, R. P., Haupts, U. M., Brown, M. J. B., and Pope, A. J. (2001) Real experience of uHTS: a prototypic 1536-well fluorescence anisotropy-based uHTS screen and application of well-level quality control procedures, J. Biomol. Screen., 6, 275–290.CrossRefPubMedGoogle Scholar
  28. 28.
    Yan, K., Hunt, E., Berge, J., May, E., Copeland, R. A., and Gontarek, R. R. (2005) Fluorescence polarization method to characterize macrolide-ribosome interactions, Antimicrob. Agents Chemother., 49, 3367–3372.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Li, J., Kim, I. H., Roche, E. D., Beeman, D., Lynch, A. S., Ding, C. Z., and Ma, Z. (2006) Design, synthesis, and biological evaluation of BODIPY-erythromycin probes for bacterial ribosomes, Bioorg. Med. Chem. Lett., 16, 794–797.CrossRefPubMedGoogle Scholar
  30. 30.
    Shishkina, A., Makarov, G., Tereshchenkov, A., Korshunova, G., Sumbatyan, N., Golovin, A., Svetlov, M., and Bogdanov, A. (2013) Conjugates of amino acids and peptides with 5-Omycaminosyltylonolide and their interaction with the ribosomal exit tunnel, Bioconjug. Chem., 24, 1861–1869.CrossRefPubMedGoogle Scholar
  31. 31.
    Glassford, I., Lee, M., Wagh, B., Velvadapu, V., Paul, T., Sandelin, G., DeBrosse, C., Klepacki, D., Small, M. C., MacKerell, A. D., Jr., and Andrade, R. B. (2014) Desmethyl macrolides: synthesis and evaluation of 4-desmethyl telithromycin, ACS Med. Chem. Lett., 5, 1021–1026.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Tereshchenkov, A. G., Shishkina, A. V., Tashlitsky, V. N., Korshunova, G. A., Bogdanov, A. A., and Sumbatyan, N. V. (2016) Interaction of chloramphenicol tripeptide analogs with ribosomes, Biochemistry (Moscow), 81, 392–400.CrossRefGoogle Scholar
  33. 33.
    Sumbatyan, N. V., Kuznetsova, I. V., Karpenko, V. V., Fedorova, N. V., Chertkov, V. A., Korshunova, G. A., and Bogdanov, A. A. (2010) Amino acid and peptide derivatives of the tylosin family of macrolide antibiotics modified by aldehyde function, Russ. J. Bioorg. Chem., 36, 245–256.CrossRefGoogle Scholar
  34. 34.
    Noll, M., Hapke, B., and Noll, H. (1973) Structural dynamics of bacterial ribosomes, II. Preparation and characterization of ribosomes and subunits in the translation of natural messenger RNA, J. Mol. Biol., 80, 519–529.CrossRefPubMedGoogle Scholar
  35. 35.
    Milon, P., Konevega, A. L., Peske, F., Fabbretti, A., Gualerzi, C. O., and Rodnina, M. V. (2007) Transient kinetics, fluorescence, and FRET in studies of initiation of translation in bacteria, Methods Enzymol., 43, 1–30.CrossRefGoogle Scholar
  36. 36.
    Yang, X. F., Guo, X. Q., and Zhao, Y. B. (2002) Development of a novel rhodamine-type fluorescent probe to determine peroxynitrite, Talanta, 57, 883–890.PubMedGoogle Scholar
  37. 37.
    Onoda, M., Uchiyama, S., Santa, T., and Imai, K. (2002) A photoinduced electron-transfer reagent for peroxyacetic acid, 4-ethylthioacetylamino-7-phenylsulfonyl-2,1,3-benzoxadiazole, based on the method for predicting the fluorescence quantum yields, Anal. Chem., 74, 4089–4096.PubMedGoogle Scholar
  38. 38.
    Jablonski, A. (1960) On the notion of emission anisotropy, Bull. Acad. Pol. Sci., 8, 259–264.Google Scholar
  39. 39.
    Copeland, R. A. (2000) Enzymes: A Practical Introduction to Structure, Mechanism and Data Analysis, 2nd Edn., WileyVCH, New York, N. Y.CrossRefGoogle Scholar
  40. 40.
    Wang, Z. X. (1995) An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule, FEBS Lett., 360, 111–114.CrossRefPubMedGoogle Scholar
  41. 41.
    Sumbatyan, N. V., Korshunova, G. A., and Bogdanov, A. A. (2003) Peptide derivatives of antibiotics tylosin and desmycosin, protein synthesis inhibitors, Biochemistry (Moscow), 68, 1156–1158.CrossRefGoogle Scholar
  42. 42.
    Goldman, R. C., Zakula, D., Flamm, R., Beyer, J., and Capobianco, J. (1994) Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes, Antimicrob. Agents Chemother., 38, 1496–1500.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Douthwaite, S., Hansen, L. H., and Mauvais, P. (2000) Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA, Mol. Microbiol., 36, 183–193.CrossRefPubMedGoogle Scholar
  44. 44.
    Karahalios, P., Kalpaxis, D. L., Fu, H., Katz, L., Wilson, D. N., and Dinos, G. P. (2006) On the mechanism of action of 9-O-arylalkyloxime derivatives of 6-Omycaminosyltylonolide, a new class of 16-membered macrolide antibiotics, Mol. Pharmacol., 70, 1271–1280.CrossRefPubMedGoogle Scholar
  45. 45.
    Mamos, P., Krokidis, M. G., Papadas, A., Karahalios, P., Starosta, A. L., Wilson, D. N., Kalpaxis, D. L., and Dinos, G. P. (2013) On the use of the antibiotic chloramphenicol to target polypeptide chain mimics to the ribosomal exit tunnel, Biochimie, 95, 1765–1772.CrossRefPubMedGoogle Scholar
  46. 46.
    Contreras, A., and Vazquez, D. (1977) Cooperative and antagonistic interactions of peptidyl-tRNA and antibiotics with bacterial ribosomes, Eur. J. Biochem., 74, 539–547.CrossRefPubMedGoogle Scholar
  47. 47.
    Hansen, J., Ippolito, J., Ban, N., Nissen, P., Moore, P., and Steitz, T. (2002) The structures of four macrolide antibiotics bound to the large ribosomal subunit, Mol. Cell, 10, 117–128.CrossRefPubMedGoogle Scholar
  48. 48.
    Schlunzen, F., Zarivach, R., Harms, J., Bashan, A., Tocilj, A., Albrecht, R., Yonath, A., and Franceschi, F. (2001) Structural basis for the interaction of antibiotics with the peptidyl transferase center in eubacteria, Nature, 413, 814–821.CrossRefPubMedGoogle Scholar
  49. 49.
    Hansen, J. L., Moore, P. B., and Steitz, T. A. (2003) Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit, J. Mol. Biol., 330, 1061–1075.CrossRefPubMedGoogle Scholar
  50. 50.
    Huang, X. (2003) Fluorescence polarization competition assay: the range of resolvable inhibitor potency is limited by the affinity of the fluorescent ligand, J. Biomol. Screen., 8, 34–38.CrossRefPubMedGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2016

Authors and Affiliations

  • A. G. Tereshchenkov
    • 1
  • A. V. Shishkina
    • 2
  • V. V. Karpenko
    • 1
  • V. A. Chertkov
    • 1
  • A. L. Konevega
    • 3
    • 4
  • P. S. Kasatsky
    • 3
    • 4
  • A. A. Bogdanov
    • 1
    • 2
  • N. V. Sumbatyan
    • 1
    Email author
  1. 1.Faculty of ChemistryLomonosov Moscow State UniversityMoscowRussia
  2. 2.Belozersky Institute of Physico-Chemical BiologyLomonosov Moscow State UniversityMoscowRussia
  3. 3.Molecular and Radiation Biophysics Division, Konstantinov Petersburg Nuclear Physics InstituteNational Research Center “Kurchatov Institute”GatchinaRussia
  4. 4.Peter the Great Saint-Petersburg Polytechnic UniversitySt. PetersburgRussia

Personalised recommendations